Lixte Biotechnology Changes Principal Executive Offices
Ticker: LIXT · Form: 8-K · Filed: May 20, 2025 · CIK: 1335105
Sentiment: neutral
Topics: administrative, office-move
Related Tickers: LIXT
TL;DR
LIXT moved its HQ to Pasadena, CA.
AI Summary
On May 16, 2025, LIXTE BIOTECHNOLOGY HOLDINGS, INC. filed an 8-K report detailing an event. The filing indicates a change in the company's principal executive offices to 680 East Colorado Boulevard, Suite 180, Pasadena, California 91101. The report was filed on May 20, 2025.
Why It Matters
A change in principal executive offices can signal operational shifts or strategic realignments within the company.
Risk Assessment
Risk Level: low — This filing reports a change in address, which is a routine administrative event with no immediate financial or operational risk.
Key Players & Entities
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (company) — Filer
- May 16, 2025 (date) — Earliest event reported
- May 20, 2025 (date) — Filing date
- 680 East Colorado Boulevard, Suite 180 Pasadena, California 91101 (location) — New principal executive offices
FAQ
What is the new address for Lixte Biotechnology Holdings, Inc.'s principal executive offices?
The new address is 680 East Colorado Boulevard, Suite 180, Pasadena, California 91101.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 16, 2025.
On what date was this 8-K filing submitted to the SEC?
The filing was submitted on May 20, 2025.
What is the company's IRS Employer Identification Number?
The IRS Employer Identification Number is 20-2903526.
What is the company's telephone number?
The company's telephone number is (631) 830-7092.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 20, 2025 regarding LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT).